Biocompatibility Innovation
Biostealth Technology Platform for
Medical Devices
Long-lasting, durable medical devices mean fewer invasive procedures and improved quality of life for patients.
The low biocompatibility of current medical devices remains a leading cause of device failure and patient complications.
BCI develops technologies engineered to enhance device biocompatibility, enabling more durable, longer-lasting medical devices while preserving full functionality.
By mitigating the biological processes associated with device failure, BCI’s platform is designed to extend device longevity and support improved long-term clinical management.
Biostealth Technology
Our ultra-thin, non-eluting biostealth technologies permanently bond with the materials used in medical devices without altering their original physical or functional properties.
Engineered as plant-based add-on technologies, BCI’s platform is rapidly scalable.
Our patented technologies create a protective interface designed to inhibit inflammation, calcification, thrombosis, infection, and immune-mediated reactions.
BCI’s proprietary technologies offer tailored solutions for a broad range of materials, devices, and clinical applications.
Together, they enable BCI to address multiple device categories through a single adaptable platform.
One Platform. Multiple Solutions.
Our Solutions
A proprietary platform engineered for diverse materials and medical applications, adaptable to specific clinical and manufacturing needs.
Barrier Against Failure
BCI technologies are built to limit the post-implant biological processes that contribute to device degeneration, supporting durable device function over time.
Partnerships
